Latest news with #Mittal
Business Insider
4 hours ago
- Business
- Business Insider
UPM Kymmene (0NV5) Gets a Buy from Barclays
Barclays analyst Pallav Mittal maintained a Buy rating on UPM Kymmene (0NV5 – Research Report) today. The company's shares closed yesterday at €23.76. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Mittal is an analyst with an average return of -2.0% and a 40.82% success rate. Mittal covers the Basic Materials sector, focusing on stocks such as Stora Enso Oyj, Mondi plc, and UPM Kymmene. Currently, the analyst consensus on UPM Kymmene is a Strong Buy with an average price target of €31.57, which is a 32.87% upside from current levels. In a report released on June 17, Jefferies also maintained a Buy rating on the stock with a €28.60 price target.
&w=3840&q=100)
Business Standard
8 hours ago
- Business
- Business Standard
SastaSundar to invest Rs 150 crore in 2 yrs, aims turnaround in FY26
SastaSundar Ventures Ltd is in the process of investing Rs 150 crore over the next two years to strengthen its digital healthcare platform and warehousing infrastructure to make a turnaround and return to profit in FY'26, a company official said on Thursday. The investment will largely be funded through a Rs 145-crore capital pool, created from the Flipkart Health exit settlement and internal treasury income. The Kolkata-based online pharmacy ended its partnership with Flipkart Health earlier this year and relaunched its B2C platform under its own brand. "We are aiming to return to net profit in the current fiscal through strategic initiatives. We are focusing on the execution of these and capital-efficient growth to recover the company from a Rs 122 crore net loss in FY'25. "Out of the Rs 150 crore, about Rs 40 crore was deployed in FY'25, and the remaining Rs 110 crore will be invested in FY'26 and FY'27," SastaSundar Chairman B L Mittal told PTI. To tap into the rising demand for affordable medication, SastaSundar has launched JITO, a curated generics medicine channel under its main brand. "We expect to invest nearly Rs 25 crore to develop the JITO platform to push retail sales," Mittal said. The concept of quality-verified generic substitutes is gaining popularity, offering customers significant discounts compared to branded prescription drugs. With a Rs 50-crore investment planned in technology and AI-driven healthcare tools, the company is targeting to double its B2C business in FY'26, from Rs 144 crore achieved in FY'25. A major portion of this investment will go towards hiring tech and AI talent to build digital consultation, diagnostics, and personal health profiling tools, Mittal recently informed investors in a conference call. On the distribution side, 250 Health Buddies are currently active post the Flipkart exit, and the company expects this number to rise to around 400 by the end of FY'26, he said. On the B2B front, RetailerShakti, which supplies to pharmacies, delivered a strong performance with revenue nearly doubling to Rs 941 crore in FY'25, he said. The company is targeting EBITDA breakeven for RetailerShakti in the last quarter of FY'26. By FY'30, SastaSundar aims to achieve a blended EBITDA margin of 4-5 per cent.
&w=3840&q=100)
Business Standard
8 hours ago
- Business
- Business Standard
Bharti Airtel hits new high, up 40% in 1 year; brokerages see more upside
Bharti Airtel share price today: Shares of Bharti Airtel hit a record high of ₹1,924, as they rallied 3 per cent on the BSE in Friday's intra-day trade on the back of heavy volumes amid a healthy outlook. The stock price of the telecom services provider has surpassed its previous high of ₹1,916.90, which it touched on May 7, 2025. Thus far in the calendar year 2025, Bharti Airtel has outperformed the market by surging 20 per cent, as compared to a 4.5 per cent rise in the BSE Sensex. In the past year, the stock zoomed 40 per cent, as against a 6 per cent gain in the benchmark index. Reliance Jio initial public offering Mukesh Ambani's telecom giant, Reliance Jio, is reportedly planning an initial public offering (IPO) in the second half of 2025, aiming to be the largest IPO in India. According to media reports, Jio Platforms is estimated to have an enterprise value (EV) in the range of $136 billion-$154 billion at its peak. JM Financial, Mirae Asset Sharekhan see more upside Analysts at JM Financial Institutional Securities have raised Bharti's FY26-27 consolidated Ebitda estimate by 10 per cent, accounting for Indus consolidation. Hence, there is a marginal 0-1 per cent increase in profit after tax (PAT) estimate and a slight increase in target price (TP) to ₹2,050 apiece, from ₹2,035 per share earlier. The brokerage firm in its June 9, 2025, telecom report said that it reiterates a 'Buy' rating on Bharti Airtel as analysts believe India's wireless business tariff hikes are likely to be more frequent given the consolidated industry structure. Higher average revenue per user or ARPU requirement for Jio is not only to justify its significant 5G capex, but also given its potential listing plans. Bharti is the biggest beneficiary of higher tariffs, given the sticky and premium quality of its subs. ARPU growth aided by likely moderation in capex will continue to drive Bharti's free cash flow (FCF), enabling it to get to net cash by FY30; this will also aid in accretion in equity value. However, there is a possibility of continued stake sale by promoters to outside investors, which could be a near-to-medium term overhang as Singtel (effective stake at ~28.3 per cent) and the Mittal family (effective stake at ~22.9 per cent) plan to equalise their stake over a period of time. According to Mirae Asset Sharekhan, Bharti Airtel has delivered a robust performance in FY25, achieving strong revenue and Ebitda growth despite challenges such as African currency devaluation, with a focus on operational excellence and deleveraging, strengthening its balance sheet. The company is making significant strides in mobile, broadband, and digital TV segments, which are expected to be bolstered further by strategic partnerships like Apple TV and Starlink, while continuing to invest in 5G and fibre expansion. The company continues to achieve industry-leading ARPU for India mobile services, while traction from adjacent businesses and moderation of capex intensity is likely to further deleverage the balance sheet, the brokerage firm said; maintain 'buy' rating on stock with a target price of ₹2,170 per share.
New Indian Express
8 hours ago
- Politics
- New Indian Express
Telangana HC notice to Naveen Mittal in evacuee property NOC case
In the second petition, Agarwal contested a decision of the trial court which had kept in abeyance the cognisance proceedings against Mittal and other public servants due to the pending sanction under Section 197 CrPC. The petitioner alleged that the NOCs were issued illegally to third parties in criminal collusion with other accused persons. She claimed that forged and fabricated documents were used and that the NOCs were issued with false recitals. She also alleged that objections raised by her were recorded without her being served any notice or given an opportunity to be heard. The NOC proceedings allegedly went so far as to declare the title and possession in favour of the applicants, effectively undermining her own claim to the property. Agarwal asserted that the entire process was aimed at misclassifying the disputed land as 'non-evacuee' property, thereby nullifying her title which is based on GO No 388 dated December 20, 1954. This government order had declared the subject land as evacuee property, forming the basis of her claim. The two writ petitions came up for hearing before separate Single Judge Benches — one headed by Justice K Lakshman and the other by Justice N Tukaramji. After hearing the submissions, both benches issued notices to Mittal.
Business Insider
9 hours ago
- Business
- Business Insider
Singtel (SNGNF) Receives a Buy from DBS
DBS analyst Sachin Mittal maintained a Buy rating on Singtel (SNGNF – Research Report) today and set a price target of S$4.58. The company's shares closed last Tuesday at $3.16. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Mittal is a top 100 analyst with an average return of 22.4% and a 73.48% success rate. Mittal covers the Technology sector, focusing on stocks such as Accenture, Cognizant, and Infosys. Currently, the analyst consensus on Singtel is a Moderate Buy with an average price target of $3.31. Based on Singtel's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $6.99 billion and a net profit of $1.23 billion. In comparison, last year the company earned a revenue of $7.03 billion and had a net profit of $2.14 billion
